MeiraGTx (MGTX)
(Delayed Data from NSDQ)
$7.65 USD
0.00 (0.00%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $7.66 +0.01 (0.13%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
MeiraGTx Holdings PLC's dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
MGTX 7.65 0.00(0.00%)
Will MGTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MGTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MGTX
3 Promising Genomics Stocks to Keep an Eye On in 2025
MeiraGTx Holdings PLC (MGTX) Reports Q1 Loss, Misses Revenue Estimates
MGTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Beam Therapeutics (BEAM) Moves 12.6% Higher: Will This Strength Last?
AnaptysBio (ANAB) Moves 9.5% Higher: Will This Strength Last?
MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Tops Revenue Estimates
Other News for MGTX
Insider Sell Alert: Alexandria Forbes Sells 47,500 Shares of MeiraGTx Holdings PLC
Prosight Management, LP's Strategic Acquisition in Mural Oncology PLC
MeiraGTx Gains UK Approval for Hologen Transactions
Meiragtx Holdings (MGTX) Receives a New Rating from Lucid Capital
Lucid Capital Initiates Buy Rating on MeiraGTx (MGTX) with $50 Target | MGTX Stock News